IL2 and liver cancer: The induction of proinflammatory cytokine and chemokines (interleukin-2) is detrimental among primary liver cancer patients who have undergone hepatectomy (Sachdeva et al., 2015; Sachdeva and Arora, 2020; Cai et al., 2022; Chen et al., 2022; Lu et al., 2022).